Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
GRFS
#5352
Grifols, S.A. - American Depositary Shares
7.0
1
USD
-0.03%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-2.64%
Monthly Change
-9.31%
6 month change
-23.47%
Year Change
-29.90%
Previous Close
7.2
0
Open
7.0
3
Low
7.0
0
High
7.0
4
Volume
238
Markets
US Stock Market
Healthcare
Drug Manufacturers—General
GRFS
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2020
2021
2022
2023
2024
2025
Total assets
—
—
—
—
—
—
Total liabilities
—
—
—
—
—
—
Total equity
—
—
—
—
—
—
Total liabilities & shareholders' equities
—
—
—
—
—
—
Total debt
—
—
—
—
—
—
Net debt
—
—
—
—
—
—
News
Is ADMA Stock's 13.5% Monthly Gain a Sign of Recovery?
Grifols: Operational Recovery And Balance Sheet Improvement Support A Return To Buy
Grifols: Plasma Self-Sufficiency Is The Mispriced Catalyst (NASDAQ:GRFS)
Can Asceniv Help ADMA Navigate the Current IG Market Challenges?
Will the IG Market Challenges Affect ADMA Biologics Prospects in 2026?
Is it Time to Exit ADMA Biologics Stock After a 22% Monthly Plunge?
Will the Label Expansion of Asceniv Boost ADMA's Top-Line Growth?
Will Asceniv Deliver for ADMA in the Upcoming Quarterly Results?
Will Asceniv Deliver for ADMA in the Upcoming Quarterly Results?
Does ADMA Biologics' Growth Story Outweigh Short-Seller Concerns?
ADMA Crashes 42.5% YTD: Right Time to Buy the Stock?
Is ADMA Poised for Margin Growth and Supply Expansion in 2026?